✦ LIBER ✦

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the study group of Japan

✍ Scribed by Shigenori Sawaguchi; Michio Kaneko; Jun-Ichi Uchino; Takeo Takeda; Makoto Iwafuchi; Shiro Matsuyama; Hideyo Takahashi; Toshio Nakajo; Yasutaka Hoshi; Ikuo Okabe; Jotaro Yokoyama; Hirokazu Nishihira; Shingi Sasaki; Minoru Sakurai; Tadashi Sawada; Noboru Nagahara; Yoshiaki Tsuchida

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 691 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19901101)66:9<1879::aid-cncr2820660905>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of patients with advanced neu

Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: A report from the study group of Japan for treatment of advanced neuroblastoma

✍ Iwafuchi, Makoto; Utsumi, Jiro; Tsuchida, Yoshiaki; Kaneko, Michio; Matsuyama, S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

In January 1985, a single protocol consisting of cyclophosphamide, vincristine, tetrahydropyranyl adriamycin, and cis-platinum for the treatment of advanced neuroblastoma was begun nationwide in Japan and was found to improve clinical results significantly in terms of 2-or 3year survival rate. Betw

13-cis-retinoic acid (NSC 122758) in the

13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group

✍ Finklestein, Jerry Z. ;Krailo, Mark D. ;Lenarsky, Carl ;Ladisch, Stephen ;Blair, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

## Abstract The Childrens Cancer Study Group evaluated daily oral 13‐cis‐retinoic acid to determine its therapeutic efficacy in 28 children with advanced neuroblastoma refractory to conventional therapy. Cheilitis and fissured lips were the most common side effects; however, fewer than 50% of the p

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.

Chemotherapy as a substitute for surgery

Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group

✍ Charlotte Jacobs; Don R. Goffinet; Linda Goffinet; Marsha Kohler; Willard E. Fee 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Treatment of children with stage IV favo

Treatment of children with stage IV favorable histology Wilms tumor: A report from the National Wilms Tumor Study Group

✍ Green, Daniel M.; Breslow, Norman E.; Evans, Ilonka; Moksness, Jami; D'Angio, Gi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran

Venoocclusive disease of the liver after

Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma : A report of the Intergroup Rhabdomyosarcoma Study Group

✍ Jorge A. Ortega; Sarah S. Donaldson; S. Percy Ivy; Alberto Pappo; Harold M. Maur 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 3 views

after allogenic and autologous bone marrow transplantation for malignant disease.